文献速递心胸血管麻醉

高危心脏手术患者围术期门静脉血流搏动性的多普勒超声评估:多中心前瞻性队列研究

Perioperative Doppler ultrasound assessment of portal vein flow pulsatility in high-risk cardiac surgery patients: a multicentre prospective cohort study.
PubMed 文献 · Br J Anaesth · 2022-09-30

该多中心前瞻性队列研究纳入373例高危心脏手术患者,在麻醉后CPB前和CPB脱机后行门静脉脉冲波多普勒超声,定义异常搏动为PPF≥50%。CPB前PPF50与28天内需要侵入性生命支持的累积时间更长相关,CPB后PPF50与主要术后并发症发生率更高相关,但后者校正混杂因素后非独立相关。

要点

  • CPB前门静脉PPF≥50%与术后28天内侵入性生命支持时间更长独立相关。
  • CPB后PPF≥50%与主要术后并发症发生率更高相关,但校正后非独立。
  • 围术期经食管超声门静脉多普勒可用于评估静脉淤血的血流动力学影响。

核心结论

  • CPB前门静脉血流搏动性异常(PPF≥50%)与高危心脏手术患者术后需要侵入性生命支持的时间更长相关。
  • CPB脱机后门静脉血流搏动性异常与主要术后并发症风险更高相关,但该关联校正其他因素后不独立。

研究设计与样本

  • 多中心前瞻性队列研究,纳入373例高危心脏手术患者。
  • 在麻醉后CPB前和CPB脱机后行门静脉脉冲波多普勒超声,异常搏动定义为门静脉搏动分数(PPF)≥50%(PPF50)。
  • 主要结局为28天内围术期器官功能障碍需要侵入性生命支持的累积时间(TPOD)。

主要发现

  • CPB前71例(22.0%)存在PPF50,CPB后77例(24.9%)存在PPF50。
  • CPB前PPF50组TPOD中位数27 h(IQR 11–72) vs 19 h(IQR 8.5–42),P=0.02。
  • CPB后PPF50组TPOD中位数27 h(IQR 11–61) vs 20 h(IQR 8–42),P=0.006。
  • 校正混杂因素后,CPB前PPF50与TPOD显著相关。
  • CPB后PPF50组主要术后并发症发生率36.4% vs 20.3%,P=0.006。

关键数值与推荐

  • 异常门静脉血流搏动性定义为门静脉搏动分数(PPF)≥50%(PPF50)。
  • 主要结局为28天内围术期器官功能障碍需要侵入性生命支持的累积时间(TPOD)。

临床怎么用

  • 高危心脏手术患者围术期可考虑用经食管超声多普勒评估门静脉血流搏动性,辅助识别静脉淤血相关风险。
  • CPB前检出PPF≥50%提示术后可能需要更长时间的侵入性生命支持,应加强术后监护资源准备。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Portal vein Doppler ultrasound pulsatility measured by transoesophageal echocardiography is a marker of the haemodynamic impact of venous congestion in cardiac surgery. We investigated whether the presence of abnormal portal vein flow pulsatility is associated with a longer duration of invasive life support and postoperative complications in high-risk patients. METHODS: In this multicentre cohort study, pulsed-wave Doppler ultrasound assessments of portal vein flow were performed during anaesthesia before initiation of cardiopulmonary bypass (before CPB) and after separation of cardiopulmonary bypass (after CPB). Abnormal pulsatility was defined as portal pulsatility fraction (PPF) ≥50% (PPF50). The primary outcome was the cumulative time in perioperative organ dysfunction (TPOD) requiring invasive life support during 28 days. Secondary outcomes included major postoperative complications. RESULTS: 373 patients, 71 (22.0%) had PPF50 before CPB and 77 (24.9%) after CPB. PPF50 was associated with longer duration of TPOD (median [inter-quartile range]; before CPB: 27 h [11-72] vs 19 h [8.5-42], P=0.02; after CPB: 27 h [11-61] vs 20 h [8-42], P=0.006). After adjusting for confounders, PPF50 before CPB showed significant association with TPOD. PPF50 after CPB was associated with a higher rate of major postoperative complications (36.4% vs 20.3%, P=0.006). CONCLUSIONS: Abnormal portal vein flow pulsatility before cardiopulmonary bypass was associated with longer duration of life support therapy after cardiac surgery in high-risk patients. Abnormal portal vein flow pulsatility after cardiopulmonary bypass separation was associated with a higher risk of major postoperative complications although this association was not independent of other factors. CLINICAL TRIAL REGISTRATION: NCT03656263.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Denault A, Couture EJ, De Medicis É, et al. Perioperative Doppler ultrasound assessment of portal vein flow pulsatility in high-risk cardiac surgery patients: a multicentre prospective cohort study. Br J Anaesth. 2022. PMID: 36184294. doi:10.1016/j.bja.2022.07.053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。